Answer
Nausea, diarrhoea and vomiting are listed as very common with ambrisentan, with vomiting’s frequency observed in a placebo-controlled study of ambrisentan combined with tadalafil and a lower incidence observed with ambrisentan monotherapy.
Sources for this answer
- Volibris 5 mg film coated tabletsGlaxoSmithKline UK · emc · SmPC §4.8 Undesirable effects · Version 28Document updated
Sources checked